Product NDC: | 68016-117 |
Proprietary Name: | Senna |
Non Proprietary Name: | SENNOSIDES |
Active Ingredient(s): | 8.6 mg/1 & nbsp; SENNOSIDES |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68016-117 |
Labeler Name: | Chain Drug Consortium, LLC (Premier Value) |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part334 |
Marketing Category: | OTC MONOGRAPH NOT FINAL |
Start Marketing Date: | 20110418 |
Package NDC: | 68016-117-00 |
Package Description: | 1 BOTTLE in 1 BOX (68016-117-00) > 100 TABLET in 1 BOTTLE |
NDC Code | 68016-117-00 |
Proprietary Name | Senna |
Package Description | 1 BOTTLE in 1 BOX (68016-117-00) > 100 TABLET in 1 BOTTLE |
Product NDC | 68016-117 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | SENNOSIDES |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20110418 |
Marketing Category Name | OTC MONOGRAPH NOT FINAL |
Labeler Name | Chain Drug Consortium, LLC (Premier Value) |
Substance Name | SENNOSIDES |
Strength Number | 8.6 |
Strength Unit | mg/1 |
Pharmaceutical Classes |